June 5, 2021: PD Neurotechnology®, an award-winning medical device company, is a founding member of the collaborative innovation cluster "Hellenic Digital Health Cluster (HDHC)", which aims to strengthen Greece's presence in the field of digital health.
HDHC brings together selected companies and organizations in the field of digital health in Greece, aiming at growth, innovation strengthening, capacity building and extroversion. The initiative which is supported by the Center for eHealth Applications and Services (CeHA) of the of FORTH and PRAXI Network, is co-financed by the Operational Program "Competitiveness, Entrepreneurship, Innovation" (EPAnEK) and consists so far of 20 companies.
PD Neurotechnology Ltd is an awarded, medical device company, founded in London, UK in 2015. It is certified with ISO 9001:2015, ISO 27001:2013, ISO 27701:2019 and ISO 13485:2016 by DQS MED Germany. Its first product, PDMonitor® is a CE marked, Class IIa medical device, a digital, non-invasive, continuous monitoring system used by patients with Parkinson’s Disease, which enables an accurate motor symptom evaluation, coupled with information on lifestyle and drug adherence. A web application offers the treating physician a comprehensive and objective view of the patient status and supports the assessment of the disease stage and prompt and optimal modification of the treatment. It is a user-friendly management tool and electronic patient record. PD Neurotechnology Limited is in Sales, since September 2020, currently present in more than 10 European countries, soon to launch in the USA. More than 30 global KOLs endorse PDMonitor®, a number of strategic collaborations are in progress or have been signed and reimbursement is expected in various countries, starting from 2022.
You can find the press release here.